Status:
COMPLETED
Vascular and Skeletal Protective Effects of Genistein in Postmenopausal Women
Lead Sponsor:
University of Messina
Conditions:
Menopause
Osteopenia
Eligibility:
FEMALE
45-70 years
Phase:
PHASE2
PHASE3
Brief Summary
The present research program is proposed deepening some pharmacological effects of the genistein therapy in order to individualize alternative treatments to the conventional hormonal replacement thera...
Detailed Description
Genistein is a phytoestrogen of the isoflavone family which has been shown to have beneficial effects on endothelial function and bone metabolism. On the basis of the so far obtained results, aim of o...
Eligibility Criteria
Inclusion
- At least one year of menopause
- No use of hormone replacement therapy
- Bone mineral density T-score at the femoral neck minor than one S.D.
Exclusion
- Concomitant disease
- Smoke habit
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
End Date :
June 1 2005
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00355953
Start Date
January 1 2003
End Date
June 1 2005
Last Update
April 22 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.